Understanding Repeat Positive HIV Testing in South Africa Under Changing Treatment Guidelines.

Journal: AIDS and behavior

Volume: 26

Issue: 5

Year of Publication: 2022

Affiliated Institutions:  Division of Global Health Equity, Brigham and Women's Hospital, Thorn Building th Floor, Boston, MA, , USA. mnardell@bwh.harvard.edu. Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA. Department of Human Development and Family Sciences, University of Delaware, Newark, USA. RAND Corporation, Santa Monica, USA. Perinatal HIV Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Desmond Tutu Health Foundation, University of Cape Town Medical School, Cape Town, South Africa. Department of Global Health, Boston University School of Public Health, Boston, USA. Oregon Health & Science University-Portland State University School of Public Health, Portland, USA. Harvard Medical School, Boston, USA.

Abstract summary 

Some people with HIV (PWH) test positive multiple times without initiating antiretroviral therapy (ART). We surveyed 496 ART-eligible PWH following routine HIV testing at three clinics in Soweto and Gugulethu, South Africa in 2014-2015. Among repeat positive testers (RPTs) in this cohort, we compared rates of treatment initiation by prior treatment eligibility and assessed psychosocial predictors of treatment initiation in logistic regression models. RPTs represented 33.8% of PWH in this cohort. Less than half of those who reported eligibility for ART on prior testing started treatment upon retesting, in contrast to two thirds of RPTs who were previously ineligible for treatment who started treatment once they learned of their eligibility. Those who reported coping through substance use were more likely to decline treatment versus those not using substances. PWH who test repeatedly represent a vulnerable population at risk for ART non-initiation who may benefit from interventions addressing individualized coping strategies.

Authors & Co-authors:  Nardell Maria F MF Hedt-Gauthier Bethany B Earnshaw Valerie A VA Bogart Laura M LM Dietrich Janan J JJ Courtney Ingrid I Tshabalala Gugulethu G Bor Jacob J Orrell Catherine C Gray Glenda G Bangsberg David R DR Katz Ingrid T IT

Study Outcome 

Source Link: Visit source

Statistics
Citations :  South Africa 90–90-90 progress [Internet]. Avert. 2018. [cited 2020 Oct 28]. Available from: https://www.avert.org/infographics/south-africa-90-90-90-progress
Authors :  12
Identifiers
Doi : 10.1007/s10461-021-03493-5
SSN : 1573-3254
Study Population
Male,Female
Mesh Terms
Anti-HIV Agents
Other Terms
Antiretroviral treatment initiation;Coping;Repeat positive testing;Retesting;South Africa
Study Design
Cross Sectional Study
Study Approach
Country of Study
South Africa
Publication Country
United States